EcoDrugPlus

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSBMSG00010003770
Gene Symbol: S1PR1
1 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSBMSG00010005143
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSBMSG00010008918
Gene Symbol: SRD5A2
1 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSBMSG00010003637
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSBMSG00010000317
Gene Symbol: SI
1 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSBMSG00010005966
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSBMSG00010022290
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSBMSG00010008106
Gene Symbol: TACR3
1 Cross references
258 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSBMSG00010013889
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSBMSG00010015590
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSBMSG00010008203
Gene Symbol: TBXA2R
1 Cross references
194 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSBMSG00010001416
Gene Symbol: THRB
1 Cross references
393 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).